OKUROnKure Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of OnKure Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OKURThis | $103M#9 | — | 0.6x#3 | — | — | -13.0%#9 | — | -34.6%#4 | — | — | -22.2%#3 | — |
| SPRB | $127M#2 | — | 1.5x#6 | — | -100.0%#6 | 26.5%#4 | — | -46.5%#6 | — | — | — | — |
| FHTX | $127M#1 | — | — | 4.1x#2 | 36.8%#2 | 14.2%#5 | -279.5%#2 | — | — | — | — | — |
| CATX | $116M#3 | — | 0.4x#1 | 80.8x#4 | — | -30.1%#11 | -7919.4%#7 | -31.8%#3 | -41.0%#3 | — | — | — |
| NERV | $116M#4 | — | — | — | — | -20492.7%#15 | — | — | — | — | — | — |
| HURA | $112M#5 | — | 6.1x#9 | — | — | -34.8%#12 | — | -167.6%#11 | -0.1%#2 | — | — | — |
| NKTX | $112M#6 | — | 0.5x#2 | — | — | 4.3%#7 | — | -42.0%#5 | — | — | -24.0%#4 | — |
| ANIX | $107M#7 | — | 7.4x#10 | 511.5x#7 | 0.0%#4 | 13.0%#6 | -5571.9%#6 | -75.5%#8 | -87.0%#4 | — | -25.2%#5 | — |
| ORGO | $102M#10 | — | 0.7x#4 | 0.2x#1 | 17.0%#3 | 4011.1%#1 | 7.9%#1 | 25.0%#1 | 23.2%#1 | — | — | — |
| IMUX | $106M#8 | 3.8x#1 | 0.8x#5 | — | — | 3.3%#8 | — | -76.2%#9 | — | — | 4.3%#1 | — |
| UNCY | $98M#11 | — | 1.8x#7 | 145.3x#6 | -29.0%#5 | 27.7%#3 | -4372.9%#5 | -49.8%#7 | — | — | -19.7%#2 | — |
| LEXX | $95M#12 | — | 20.1x#12 | 135.0x#5 | 52.0%#1 | -105.4%#14 | -1683.0%#4 | -251.2%#12 | — | — | — | — |
| NRXP | $95M#13 | — | — | 77.4x#3 | — | -13.9%#10 | -1324.4%#3 | — | — | — | — | — |
| MIST | $93M#14 | — | 5.1x#8 | — | — | -51.9%#13 | — | -0.3%#2 | — | — | — | — |
| PLYX | $93M#15 | — | 8.5x#11 | — | — | 70.4%#2 | — | -82.1%#10 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice